INJ Lee, et al. Linguistic Validation of TS-VAS and OAB-SAT-q INTRODUCTION Patient-reported outcomes (PROs) are important for assessing patients satis

Similar documents
Jkcs022(89-113).hwp

Rheu-suppl hwp

ๆญฏ1.PDF

Journal of Educational Innovation Research 2017, Vol. 27, No. 2, pp DOI: : Researc

012์ž„์ˆ˜์ง„


์„œ๋ก 



[ ์˜์–ด์˜๋ฌธํ•™ ] ์ œ 55 ๊ถŒ 4 ํ˜ธ (2010) ( ) ( ) ( ) 1) Kyuchul Yoon, Ji-Yeon Oh & Sang-Cheol Ahn. Teaching English prosody through English poems with clon

< D B4D9C3CAC1A120BCD2C7C1C6AEC4DCC5C3C6AEB7BBC1EEC0C720B3EBBEC8C0C720BDC3B7C2BAB8C1A4BFA120B4EBC7D120C0AFBFEBBCBA20C6F2B0A E687770>

1..

Abstract Background : Most hospitalized children will experience physical pain as well as psychological distress. Painful procedure can increase anxie

<32382DC3BBB0A2C0E5BED6C0DA2E687770>

,,,.,,,, (, 2013).,.,, (,, 2011). (, 2007;, 2008), (, 2005;,, 2007).,, (,, 2010;, 2010), (2012),,,.. (, 2011:,, 2012). (2007) 26%., (,,, 2011;, 2006;


Page 2 of 5 ์•„๋‹ˆ๋‹ค means to not be, and is therefore the opposite of ์ด๋‹ค. While English simply turns words like to be or to exist negative by adding not,

YI Ggodme : The Lives and Diseases of Females during the Latter Half of the Joseon Dynasty as Reconstructed with Cases in Yeoksi Manpil (Stray Notes w

- 2 -

ร€รŒรร–รˆรฑ.hwp

230 ํ•œ๊ตญ๊ต์œกํ•™์—ฐ๊ตฌ ์ œ20๊ถŒ ์ œ3ํ˜ธ I. ์„œ ๋ก  ์ฒญ์†Œ๋…„์˜ ์–ธ์–ด๊ฐ€ ๊ฑฐ์น ์–ด์ง€๊ณ  ์žˆ๋‹ค. ๊ฐœใ……ใ„ฒ, ใ…†ใ…‚๋†ˆ(๋…„), ๋ฏธ์นœใ…†ใ„ฒ, ๋‹ฅ์ณ, ์— ์ฐฝ, ๋’ค์ ธ ๋“ฑ๊ณผ ๊ฐ™์€ ๋ง์€ ์ฃผ์œ„์—์„œ ์‰ฝ๊ฒŒ ๋“ค์„ ์ˆ˜ ์žˆ๋‹ค. ๋ง๊ณผ ๊ธ€์ด ์ ์ฐจ ๋œ์†Œ๋ฆฌ๋‚˜ ๊ฑฐ์„ผ์†Œ๋ฆฌ๋กœ ๋ฐ”๋€Œ๊ณ , ์™ธ ๊ตญ์–ด ๋‚จ์šฉ๊ณผ ์‚ฌ์ด๋ฒ„ ๋ฌธํ™”์˜ ์ต๋ช…์„ฑ ๋“ฑ

Journal of Educational Innovation Research 2016, Vol. 26, No. 2, pp DOI: * Experiences of Af

#รˆยฒยฟรซยผยฎ

์„œ๋ก  34 2

ร€รฅยพร–ยฟรยฐรญยฟรซ ยณยปรรถ

Journal of Educational Innovation Research 2018, Vol. 28, No. 1, pp DOI: * A Study on the Pe

๋ณธ๋ฌธ01

Journal of Educational Innovation Research 2019, Vol. 29, No. 1, pp DOI: * Suggestions of Ways

.. IMF.. IMF % (79,895 ). IMF , , % (, 2012;, 2013) %, %, %

Vol.259 C O N T E N T S M O N T H L Y P U B L I C F I N A N C E F O R U M

Page 2 of 6 Here are the rules for conjugating Whether (or not) and If when using a Descriptive Verb. The only difference here from Action Verbs is wh

Journal of Educational Innovation Research 2019, Vol. 29, No. 1, pp DOI: (LiD) - - * Way to


DBPIA-NURIMEDIA

์„œ๊ฐ•๋Œ€ํ•™์›123ํ˜ธ

Lumbar spine

04-๋‹ค์‹œ_๊ณ ์†์ฒ ๋„61~80p

_KF_Bulletin webcopy

Output file

step 1-1

20, 41..,..,.,.,....,.,, (relevant).,.,..??.,

๋ ˆ์ด์•„์›ƒ 1

Journal of Educational Innovation Research 2017, Vol. 27, No. 1, pp DOI: NCS : G * The Analy

Kor. J. Aesthet. Cosmetol., ๋ผ์ดํ”„์Šคํƒ€์ผ์€ ๊ฐœ์ธ ์ƒํ™œ์— ์žˆ์–ด ์‹ฌ๋ฆฌ์  ๋ฌธํ™”์  ์‚ฌํšŒ์  ๋ชจ๋“  ์ธก๋ฉด์˜ ์ƒํ™œ๋ฐฉ์‹๊ณผ ์ฐจ์ด ์ „์ฒด๋ฅผ ๋งํ•œ๋‹ค. ์ด๋Ÿฌํ•œ ๋ผ์ดํ”„์Šค ํƒ€์ผ์€ ์‚ฌ๋žŒ์˜ ๋‚ด์žฌ๋œ ๊ฐ€์น˜๊ด€์ด๋‚˜ ์š•๊ตฌ, ํ–‰๋™ ๋ณ€ํ™”๋ฅผ ํŒŒ์•…ํ•˜์—ฌ ์†Œ๋น„ํ–‰๋™๊ณผ ์‹ฌ๋ฆฌ๋ฅผ ์ถ”์ธกํ•  ์ˆ˜ ์žˆ๊ณ , ๊ฐœ์ธ์˜

. 45 1,258 ( 601, 657; 1,111, 147). Cronbach ฮฑ=.67.95, 95.1%, Kappa.95.,,,,,,.,...,.,,,,.,,,,,.. :,, ( )

27 2, 17-31, , * ** ***,. K 1 2 2,.,,,.,.,.,,.,. :,,, : 2009/08/19 : 2009/09/09 : 2009/09/30 * 2007 ** *** ( :

Journal of Educational Innovation Research 2018, Vol. 28, No. 4, pp DOI: 3 * The Effect of H

DBPIA-NURIMEDIA

Journal of Educational Innovation Research 2018, Vol. 28, No. 3, pp DOI: The Effect of Caree

<C1DF3320BCF6BEF7B0E8C8B9BCAD2E687770>

2011ยดรซร‡รยฟรธ2ยตยต 24p_0628

Journal of Educational Innovation Research 2017, Vol. 27, No. 3, pp DOI: (NCS) Method of Con

ๆญฏkjmh2004v13n1.PDF

Journal of Educational Innovation Research 2018, Vol. 28, No. 1, pp DOI: * A Analysis of

Journal of Educational Innovation Research 2018, Vol. 28, No. 4, pp DOI: * A Research Trend

04_์ด๊ทผ์›_21~27.hwp

Journal of Educational Innovation Research 2017, Vol. 27, No. 1, pp DOI: * The

DBPIA-NURIMEDIA

๋„๋น„๋ผ

ํ‡ด์ขˆ์ €๋„36ํ˜ธ-4์ฐจ-T.ps, page Preflight (2)

232 ๋„์‹œํ–‰์ •ํ•™๋ณด ์ œ25์ง‘ ์ œ4ํ˜ธ I. ์„œ ๋ก  1. ์—ฐ๊ตฌ์˜ ๋ฐฐ๊ฒฝ ๋ฐ ๋ชฉ์  ์‚ฌํšŒ๊ฐ€ ๋‹ค์›ํ™”๋ ์ˆ˜๋ก ๋‹ค์–‘์„ฑ๊ณผ ๋ณตํ•ฉ์„ฑ์˜ ์š”์†Œ๋Š” ์ฆ๊ฐ€ํ•˜๊ฒŒ ๋œ๋‹ค. ๋„์‹œ์˜ ๋ฐœ๋‹ฌ์€ ์‚ฌํšŒ์˜ ๋‹ค์› ํ™”์™€ ๋ฐ€์ ‘ํ•˜๊ฒŒ ๊ด€๋ จ๋˜์–ด ์žˆ๊ธฐ ๋•Œ๋ฌธ์— ํ˜„๋Œ€ํ™”๋œ ๋„์‹œ๋Š” ๊ฒฝ์ œ, ์‚ฌํšŒ, ์ •์น˜ ๋“ฑ์ด ๋ณตํ•ฉ์ ์œผ๋กœ ์—ฐ ๊ณ„๋˜์–ด ์žˆ์–ด ํŠน

ร†รทร€รฅยฝรƒยผยณ94ลก

Journal of Educational Innovation Research 2018, Vol. 28, No. 1, pp DOI: A study on Characte

2 - ABSTRACT The object of this study is to investigate the practical effects of Senior Employment Project, implemented by government as a part of sen

๊ธฐ๊ด€๊ณ ์œ ์—ฐ๊ตฌ์‚ฌ์—…๊ฒฐ๊ณผ๋ณด๊ณ 

<BFACBCBCC0C7BBE7C7D E687770>

16(1)-3(๊ตญ๋ฌธ)(p.40-45).fm

ๆญฏkjmh2004v13n1.PDF

๋Œ€ํ•œํ•œ์˜ํ•™์›์ „ํ•™ํšŒ์ง€24๊ถŒ6ํ˜ธ-์ „์ฒด์ตœ์ข….hwp

<B1E2C8B9BEC828BFCFBCBAC1F7C0FC29322E687770>

ๆญฏ14.์–‘๋ˆ๊ทœ.hwp

Week9

ๆญฏ5-2-13(์ „๋ฏธํฌ์™ธ).PDF

์ƒ๋‹ดํ•™์—ฐ๊ตฌ,, SPSS 21.0., t,.,,,..,.,.. (Corresponding Author): / / / Tel: /

DBPIA-NURIMEDIA

Stage 2 First Phonics


2 ๋™๋ถ์•„์—ญ์‚ฌ๋…ผ์ด 50ํ˜ธ ๊ตฌ๊ถŒํ˜‘์ •์œผ๋กœ ํ•ด๊ฒฐ๋๋‹ค ๋Š” ์ผ๋ณธ ์ •๋ถ€์˜ ์ฃผ์žฅ์— ๋Œ€ํ•ด, ์ผ๋ณธ๊ตฐ ์œ„์•ˆ๋ถ€ ๋ฌธ์ œ๋Š” ์ผ ๋ณธ ์ •๋ถ€ ๊ตฐ ๋“ฑ ๊ตญ๊ฐ€๊ถŒ๋ ฅ์ด ๊ด€์—ฌํ•œ ๋ฐ˜์ธ๋„์  ๋ถˆ๋ฒ•ํ–‰์œ„์ด๋ฏ€๋กœ ํ•œ์ผ์ฒญ๊ตฌ๊ถŒํ˜‘์ • ์— ์˜ํ•ด ํ•ด๊ฒฐ๋œ ๊ฒƒ์œผ๋กœ ๋ณผ ์ˆ˜ ์—†๋‹ค ๋Š” ๊ณต์‹ ์ž…์žฅ์„ ๋ฐํ˜”๋‹ค. ๋˜ํ•œ 2011๋…„ 8์›” ํ—Œ ๋ฒ•์žฌํŒ์†Œ๋Š”

,......

Kor. J. Aesthet. Cosmetol., ๋ฐ ์ž์•„์กด์ค‘๊ฐ๊ณผ ์ŠคํŠธ๋ ˆ์Šค์™€๋„ ๋ฐ€์ ‘ํ•œ ๊ด€๊ณ„๊ฐ€ ์žˆ๊ณ , ๋งŒ์กฑ ์ •๋„ ์— ๋”ฐ๋ผ ์ „๋ฐ˜์ ์ธ ์ƒํ™œ์—๋„ ์˜ํ–ฅ์„ ๋ฏธ์น˜๋ฏ€๋กœ ์‹ ์ฒด๋Š” ๊ฐˆ์ˆ˜๋ก ๊ฐœ ์ธ์ , ์‚ฌํšŒ์  ์ฐจ์›์—์„œ ์ค‘์š”ํ•ด์ง€๊ณ  ์žˆ๋‹ค(์•ˆํฌ์ง„, 2010). ๋”ฐ๋ผ์„œ ์™ธ๋ชจ๋งŒ์กฑ๋„๋Š” ๊ฐœ์ธ์˜ ์‹ ์ฒด๋Š” ํƒ€

11ยนรšยดรถยฑร”

12์ด๋ฌธ๊ทœ

4๋ฒˆ.hwp

Journal of Educational Innovation Research 2018, Vol. 28, No. 3, pp DOI: * Strenghening the Cap

2014 HSC Korean Continuers

A 617

<313120B9DABFB5B1B82E687770>

Journal of Educational Innovation Research 2017, Vol. 27, No. 4, pp DOI: A Study on the Opti

... ์ˆ˜์‹œ์—ฐ๊ตฌ ๊ตญ๊ฐ€๋ฌผ๋ฅ˜๋น„์‚ฐ์ •๋ฐ์ถ”์ด๋ถ„์„ Korean Macroeconomic Logistics Costs in ๊ถŒํ˜๊ตฌใ†์„œ์ƒ๋ฒ”...

<B3EDB9AEC1FD5F3235C1FD2E687770>

., (, 2000;, 1993;,,, 1994), () 65, 4 51, (,, ). 33, 4 30, 23 3 (, ) () () 25, (),,,, (,,, 2015b). 1 5,


์•ผ์ฟ ๋ฅดํŠธ2010 9์›”์žฌ์ถœ

27 2, * ** 3, 3,. B ,.,,,. 3,.,,,,..,. :,, : 2009/09/03 : 2009/09/21 : 2009/09/30 * ICAD (Institute for Children Ability

7 1 ( 12 ) ( 1912 ) 4. 3) ( ) 1 3 1, ) ( ), ( ),. 5) ( ) ). ( ). 6). ( ). ( ).


975_983 ํŠน์ง‘-ํ•œ๊ทœ์ฒ , ์ •์›ํ˜ธ

<C7D1B1B9B1A4B0EDC8ABBAB8C7D0BAB85F31302D31C8A35F32C2F75F E687770>

ๆญฏ3์ดํ™”์ง„

<31325FB1E8B0E6BCBA2E687770>

Transcription:

Official Journal of Korean Continence Society / Korean Society of Urological Research / The Korean Children s Continence and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation pissn 2093-4777 eissn 2093-6931 einj.org Mobile Web NEUROUROLOGY JOURNAL INJINTERNATIONAL Original Article https://doi.org/10.5213/inj.1734992.496 pissn 2093-4777 eissn 2093-6931 Translation and Linguistic Validation of the Korean Version of the Treatment Satisfaction Visual Analogue Scale and the Overactive Bladder Satisfaction With Treatment Questionnaire Ha Na Lee 1, Ji Yun Chae 2, Hyo Serk Lee 3, Min Soo Choo 4, Min Gu Park 5, Seo Yeon Lee 6, Seung-June Oh 7, Sung Yong Cho 8 1 Department of Urology, Seoul Metropolitan Seonam Hospital, Seoul, Korea 2 Mizlove Female Urology Clinic, Seoul, Korea 3 Department of Urology, Cheil General Hospital & Women s Healthcare Center, Kwandong University College of Medicine, Seoul, Korea 4 Department of Urology, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea 5 Department of Urology, Inje University Seoul Paik Hospital, Seoul, Korea 6 Department of Urology, Myongji Hospital, Seonam University College of Medicine, Goyang, Korea 7 Department of Urology, Seoul National University Hospital, Seoul, Korea 8 Department of Urology, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul, Korea Purpose: This study reports the development of the Korean Version of the Treatment Satisfaction Visual Analogue Scale (TS- VAS) and the Overactive Bladder Satisfaction with Treatment Questionnaire (OAB-SAT-q) based on the original versions, with subsequent linguistic validation by Korean patients with overactive bladder receiving active treatment from a physician. Methods: Translation and linguistic validation were performed in 2016. The validation process included permission for translation, forward translation, reconciliation, backward translation, cognitive debriefing, and proofreading. The original versions of the TS-VAS and OAB-SAT-q were independently translated into Korean by 2 bilingual translators and were then reconciled into a single version. The third bilingual translator performed a backward translation of the reconciled version into English. A trained interviewer and 5 Korean-speaking patients with OAB carried out the cognitive debriefing. Results: During the forward translation process, the terms used in the 2 questionnaires were adjusted to use more appropriate expressions in the Korean language than were used in the original versions. During the backward translation process, no changes were made in terms of semantic equivalence. In the cognitive debriefing session, 5 patients were asked to fill in the answers within 8 minutes; most of them reported that the translated questions were clear and easy to understand. Conclusions: The present study presents successful linguistic validation of the Korean version of the TS-VAS and OAB-SATq, which could be useful tools for evaluating treatment satisfaction in patients. Keywords: Linguistics; Patient Satisfaction; Visual Analogue Scale; Overactive Bladder, Overactive Research Ethics: This study was approved by the Institutional Review Board of the Seoul Metropolitan Government - Seoul National University Boramae Medical Center (approval number: 26-2016-60). Conflict of Interest: MSC and SYC, members of the Editorial Board of INJ, are the fourth and corresponding authors of this article. However, they played no role whatsoever in the editorial evaluation of this article or the decision to publish it. No potential conflict of interest relevant to this article was reported. Corresponding author: Sung Yong Cho https://orcid.org/0000-0001-9271-6951 Department of Urology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061, Korea E-mail: kmoretry@daum.net / Tel: +82-2-870-2394 / Fax: +82-2-870-3863 Submitted: September 14, 2017 / Accepted after revision: December 1, 2017 Copyright 2017 Korean Continence Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. www.einj.org

INJ Lee, et al. Linguistic Validation of TS-VAS and OAB-SAT-q INTRODUCTION Patient-reported outcomes (PROs) are important for assessing patients satisfaction with the treatment they receive in clinics. PROs can help guide treatment with regard to the risks and benefits of an intervention in the course of treatment [1-3]. Therefore, it is important to develop a questionnaire that accurately represents PROs in order to facilitate decision-making about treatment. The Treatment Satisfaction Visual Analogue Scale (TS-VAS) and Overactive Bladder Satisfaction with Treatment Questionnaire (OAB-SAT-q) have been used for evaluating patients satisfaction with their treatment. The visual analogue scale (VAS) is a widely accepted method for measuring the effects of disease and medical interventions with special reference to quality of life (QoL) [4-6]. The OAB-SAT-q was developed based on a review of existing instruments for measuring treatment satisfaction, input from physicians experienced in treating overactive bladder (OAB), and patient feedback. To the best of our knowledge, no Korean versions of the TS- VAS and OAB-SAT-q were previously available. Therefore, we developed a Korean version based on the original versions, with subsequent linguistic validation in Korean patients with OAB who were receiving active treatment from a physician. MATERIALS AND METHODS Original TS-VAS and OAB-SAT-q The VAS was described for the first time in 1921 by Hayes and Patterson [7]. The VAS is a simple and frequently used method to evaluate variations in pain intensity [8]. The VAS for satisfaction is a simple and valid instrument to quantify a patient s satisfaction after a treatment [9], and consists of a 100-mm-long horizontal line, with 2 descriptors representing extremes of satisfaction at the beginning and at the end of the line. Patients rate their satisfaction by making a vertical mark on the 100- mm line. The measurement in millimeters is converted to the same number of points, ranging from 0 to 100 points. The OAB-SAT-q was developed as a way to evaluate the satisfaction of patients with OAB as part of the modular International Consultation on Incontinence Questionnaire [10]. The OAB-SAT-q is a disease-specific 11-item questionnaire designed to assess patients satisfaction with their treatment in the clinical setting. The OAB-SAT-q items include effectiveness, convenience, side effects, preference for treatment, willingness to undergo the treatment again, and an assessment of global satisfaction. The response options vary depending on the content of the question and are presented on 4-, 5-, and 6-point Likert scales with anchors, such as extremely dissatisfied to extremely satisfied and extremely bothersome to not at all bothersome [10]. Translation and Linguistic Validation This study was approved by the Institutional Review Board of the Seoul Metropolitan Government - Seoul National University Boramae Medical Center (approval number: 26-2016-60). The process was designed to obtain a translated Korean version of the questionnaire that would be conceptually equivalent to the original. The translation was appropriate in terms of cultural adaptation and was supervised by the project leader of the panel. The panel consisted of 7 Korean experts who performed a typical linguistic validation process. Permission Before the study commenced, the panel contacted the copyright holder and acquired permission to translate and use the TS- VAS and OAB-SAT-q after conducting the linguistic validation process. Forward Translation The original versions of the TS-VAS and OAB-SAT-q were translated into the Korean language (versions 1.0a and 1.0b) by 2 bilingual translators who did not have medical licenses. The translations were performed independently, and the translators were not permitted to contact each other during the translation process. Reconciliation by the Panel The independently translated versions in the Korean language (versions 1.0a and 1.0b) were reconciled into a single version after several panel meetings (version 1.1). The panel discussed comprehension difficulties due to subtle differences in the nuances of the selected words and phrases. Backward Translation The reconciled version of the TS-VAS and OAB-SAT-q in the Korean language (version 1.1) was sent to a third bilingual translator. This translator translated it backward into English, and the results were compared to the original English versions of the TS- VAS and OAB-SAT-q. After the third translator completed the backward translation, the panel discussed the discrepancies be- 310 www.einj.org

Lee, et al. Linguistic Validation of TS-VAS and OAB-SAT-q INJ tween the original and the backward-translated versions of the TS-VAS and OAB-SAT-q. Some changes were made in the reconciled TS-VAS and OAB-SAT-q in the Korean language based on the outcomes of several discussions (version 1.2). Cognitive Debriefing Version 1.2 of the questionnaires was evaluated by 5 Koreanspeaking patients with OAB, who were asked whether there were any clarity issues, culturally inappropriate expressions, or difficulties in understanding the questions. The panel chose a trained interviewer who conducted a standardized in-depth interview of a small number of patients. The debriefing interviews involved paraphrasing each question of the questionnaire and indicating whether the participants had any trouble understanding the question or felt that any terms were confusing. Subsequently, the panel discussed the feedback from the 5 patients with OAB and agreed upon a new version based on the issues raised (version 1.3). Proofreading Version 1.3 was proofread to check spelling, grammar, and formatting. This resulted in the final version of the TS-VAS and OAB-SAT-q in the Korean language (version 1.4). RESULTS Forward Translation and Reconciliation As shown in Table 1, the word satisfied in the title of the original version of the TS-VAS was translated as manjok ( satisfaction ) by the 2 translators. As shown in Table 2, the 11 questions of the OAB-SAT-q were translated into Korean. Question 1, How satisfied or dissatisfied are you with the way the treatment relieves your symptoms? in the original version was directly translated as jeungsangeul wanhwasikineundeisseoseo manjok hogeun bulmanjok hasimnikka? The phrase How satisfied or dissatisfied are you with the treatment? was repeated in questions 1-3. Question 2, How satisfied or dissatisfied are you with the amount of time it takes the treatment to start working? in the original version was translated as chiryohyogwaga natananeundekkaji geollineun sigane manjok hogeun bulmanjok hasimnikka? Question 3, How satisfied or dissatisfied are you with the effectiveness of the treatment, compared to what you expected? in the original version, was translated as gidaehaetdeon dae bihayeo chiryoui hyogwae eoneujeongdo manjok hogeun bulmanjok hasimnikka? The phrase compared to what you expected was translated as gidaehaetdeon geonmankeumebihae ( compared to your expectation ) in translation 1, and as yesanghaetdeon geotboda ( than you expected ) in translation 2. The panel reconciled it as gidaehaetdeon dae bihayeo ( expected compared to ). Question 4, How convenient or inconvenient is it to take the treatment as instructed? in the original version, was directly translated as eoneujeongdo pyeolli hogeun bulpyeonhasyeotseumnikka? The word convenient was translated as yongi ( easy ) and pyeonhada ( comfortable ) in translations 1 and 2, respectively. The panel reconciled it as pyeolli ( convenient ). The word extremely was finally translated as jigeuki rather than wanjeon ( complete ) and aju ( very ). Question 5, How often did you experience side effects from your treatment? in the original version, was directly translated as eolmana jaju chiryo bujagyongeul gyeongheom hasyeotseumnikka? This question was translated in nearly the same way by both translators. Question 6, How bother- Table 1. Reconciliation after 2 forward translations of Treatment Satisfaction Visual Analogue Scale US English item EXAMPLE OF TREATMENT SATISFACTION VISUAL ANALOGUE SCALE Please place a vertical mark on the line to indicate your answer to the question below Are you satisfied with your treatment? First forward Korean translation ์น˜๋ฃŒ๋งŒ์กฑ์‹œ๊ฐ์ƒ์‚ฌ์ฒ™๋„์˜ˆ์‹œ ๋‹ค์Œ๊ณผ๊ฐ™์€์งˆ๋ฌธ์„๋‹ตํ•˜๊ธฐ์œ„ํ•ดํ•ด๋‹น์„ ์—์ˆ˜์ง์„ ์„ํ‘œ๊ธฐํ•˜์‹ญ์‹œ์˜ค. Second forward Korean translation ์˜ˆ ) ์น˜๋ฃŒ๋งŒ์กฑ๋„์‹œ๊ฐ์ƒ์‚ฌ์ฒ™๋„ ์„ ์œ„์—์„ธ๋กœ์„ ์„ํ‘œ์‹œํ•˜์—ฌ๋‹ค์Œ์งˆ๋ฌธ์—๋‹ต๋ณ€ํ•˜์‹œ๊ธฐ๋ฐ”๋ž๋‹ˆ๋‹ค. Reconciled forward Korean translation ๋‹ค์Œ์งˆ๋ฌธ์„๋‹ตํ•˜๊ธฐ์œ„ํ•ด์„ ์œ„์—์„ธ๋กœ์„ ์„ํ‘œ๊ธฐํ•ด์ฃผ์‹œ๊ธฐ๋ฐ”๋ž๋‹ˆ๋‹ค. ๊ท€ํ•˜์˜์น˜๋ฃŒ์—๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? ๊ท€ํ•˜๊ป˜์„œ๋Š”์น˜๋ฃŒ์—๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? ๊ท€ํ•˜๋Š”์น˜๋ฃŒ์—๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? No, not at all ์ „ํ˜€๊ทธ๋ ‡์ง€์•Š์Œ ์•„๋‹ˆ์š”, ์ ˆ๋Œ€๋งŒ์กฑํ•˜์ง€์•Š์Šต๋‹ˆ๋‹ค. ์•„๋‹ˆ์š”, ์ „ํ˜€๊ทธ๋ ‡์ง€์•Š์Œ Yes, completely ์™„์ „ํžˆ๋งŒ์กฑํ•จ ๋„ค, ์ „์ ์œผ๋กœ๋งŒ์กฑํ•ฉ๋‹ˆ๋‹ค. ๋„ค, ์ „์ ์œผ๋กœ๋งŒ์กฑํ•จ www.einj.org 311

INJ Lee, et al. Linguistic Validation of TS-VAS and OAB-SAT-q Table 2. Reconciliation after 2 forward translations of Overactive Bladder Satisfaction with Treatment Questionnaire (OAB-SAT-q) US English item OAB-SAT-q First forward Korean translation (Translation 1) ๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ๋งŒ์กฑ๋„์„ค๋ฌธ์กฐ์‚ฌํ™•์ธ ( ์ธ์ฆ ) Second forward Korean translation (Translation 2) Instructions ์„ค๋ช…์„ค๋ช…์„œ์ง€์‹œ์‚ฌํ•ญ Please think about how satisfied you have been with the treatment you have received in the study. The questions below will ask you to rate how satisfied or dissatisfied you are with your treatment for overactive bladder. T hinking about the past four weeks, check one box for each item that best reflects your treatment experience. 1. How satisfied or dissatisfied are you with the way the treatment relieves your symptoms? 2. How satisfied or dissatisfied are you with the amount of time it takes the treatment to start working? 3. How satisfied or dissatisfied are you with the effectiveness of the treatment, compared to what you expected? ๊ท€ํ•˜๊ฐ€์‹คํ—˜์—์ฐธ์—ฌํ•˜๋ฉฐ๋ฐ›์€์น˜๋ฃŒ์—๋Œ€ํ•ด์–ผ๋งˆ๋‚˜๋งŒ์กฑํ–ˆ๋Š”์ง€๋ฅผ์ƒ๊ฐํ•ด๋ณด์‹ญ์‹œ์˜ค. ์•„๋ž˜์˜์งˆ๋ฌธ๋“ค์€๊ท€ํ•˜์˜๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ์—๋Œ€ํ•œ๋งŒ์กฑ ( ๋˜๋Š”๋ถˆ๋งŒ์กฑ ) ์ •๋„๋ฅผํ‰๊ฐ€ํ•˜๊ธฐ์œ„ํ•œํ•ญ๋ชฉ๋“ค์ž…๋‹ˆ๋‹ค. ์ง€๋‚œ 4 ์ฃผ๋™์•ˆ๊ท€ํ•˜์˜์น˜๋ฃŒ๊ฒฝํ—˜์„๊ฐ€์žฅ์ •ํ™•ํ•˜๊ฒŒ๋ฐ˜์˜ํ•˜๋Š”์นธ์„ํ•ญ๋ชฉ๋ณ„๋กœํ‘œ์‹œํ•˜์—ฌ์ฃผ์‹ญ์‹œ์˜ค. ๊ท€ํ•˜๊ป˜์„œ๋Š”์ด์—ฐ๊ตฌ์—์„œ๋ฐ›์œผ์‹ ์น˜๋ฃŒ์—์–ด๋Š์ •๋„๋งŒ์กฑํ•˜์‹œ๋Š”์ง€์ƒ๊ฐํ•ด๋ณด์‹œ๊ธฐ๋ฐ”๋ž๋‹ˆ๋‹ค. ํ•˜๊ธฐ์งˆ๋ฌธ๋“ค์—๊ท€ํ•˜์˜๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ๋งŒ์กฑ๋„๋ฅผํ‰๊ฐ€ํ•˜์—ฌ์ฃผ์‹œ๊ธฐ๋ฐ”๋ž๋‹ˆ๋‹ค. ๊ท€ํ•˜๊ป˜์„œ๋Š”์ง€๋‚œ 4 ์ฃผ๋ฅผ์ƒ๊ฐํ•˜์‹œ์–ด๊ท€ํ•˜์˜์น˜๋ฃŒ๊ฒฝํ—˜์„๊ฐ€์žฅ์ž˜๋ฌ˜์‚ฌํ•˜๋Š”ํ•ญ๋ชฉ์„์„ ํƒํ•˜์—ฌ์ฃผ์‹œ๊ธฐ๋ฐ”๋ž๋‹ˆ๋‹ค. 1. ๊ท€ํ•˜๊ฐ€๋ฐ›๋Š”์น˜๋ฃŒ์˜์ฆ์ƒ 1. ๊ท€ํ•˜๊ป˜์„œ๋Š”์น˜๋ฃŒ๊ฐ€์ฆ์ƒ์™„์™„ํ™”ํšจ๊ณผ์—์–ผ๋งˆ๋‚˜๋งŒ์กฑํ™”ํ•˜๋Š”๋ฐ์žˆ์–ด์„œ์–ด๋Š์ •๋„ํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? ๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ ๊ฐ€์š”? 2. ์น˜๋ฃŒ๊ฐ€์ž‘์šฉํ•˜๊ธฐ๊นŒ์ง€๊ฑธ๋ฆฌ 2. ๊ท€ํ•˜๊ป˜์„œ๋Š”์น˜๋ฃŒํ•˜์‹œ๋Š”๋ฐ๋Š”์‹œ๊ฐ„์—์–ผ๋งˆ๋‚˜๋งŒ์กฑํ˜น๊ธฐ์—ฌ๋˜๋Š”์‹œ๊ฐ„์—์žˆ์–ด์„œ์–ด์€๋ถˆ๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? ๋Š์ •๋„๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ ๊ฐ€์š”? 3. ๊ท€ํ•˜๊ฐ€๊ธฐ๋Œ€ํ–ˆ๋˜๊ฒƒ๋งŒํผ์— 3. ๊ท€ํ•˜๊ป˜์„œ๋Š”์น˜๋ฃŒํšจ๊ณผ์—๋Œ€๋น„ํ•ด์น˜๋ฃŒ์˜ํšจ๊ณผ์—์–ผ๋งˆ๋‚˜ํ•ด์„œ์˜ˆ์ƒํ–ˆ๋˜๊ฒƒ๋ณด๋‹ค์–ด๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? ๋Š์ •๋„๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ ๊ฐ€์š”? Reconciled forward Korean translation ๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ๋งŒ์กฑ๋„์„ค๋ฌธ์ง€ ๊ท€ํ•˜๋Š”์ด๋ฒˆ์—ฐ๊ตฌ์—์„œ๋ฐ›์€์น˜๋ฃŒ์—์–ด๋Š์ •๋„๋งŒ์กฑํ•˜๋Š”์ง€์ƒ๊ฐํ•ด๋ณด์‹œ๊ธฐ๋ฐ”๋ž๋‹ˆ๋‹ค. ์•„๋ž˜์˜์งˆ๋ฌธ๋“ค์€๊ท€ํ•˜๊ฐ€๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ์—์–ด๋Š์ •๋„๋งŒ์กฑ๋˜๋Š”๋ถˆ๋งŒ์กฑํ•˜๋Š”์ง€๋ฅผํ‰๊ฐ€ํ• ๊ฒƒ์ž…๋‹ˆ๋‹ค. ์ง€๋‚œ 4 ์ฃผ๋™์•ˆ, ๊ท€ํ•˜์˜์น˜๋ฃŒ๊ฒฝํ—˜์„๊ฐ€์žฅ์ •ํ™•ํ•˜๊ฒŒ๋ฐ˜์˜ํ•˜๋Š”์นธ์„ํ•ญ๋ชฉ๋ณ„๋กœํ‘œ์‹œํ•˜์—ฌ์ฃผ์‹ญ์‹œ์˜ค. 1. ์น˜๋ฃŒ๊ฐ€๊ท€ํ•˜์˜์ฆ์ƒ์„์™„ํ™”์‹œํ‚ค๋Š”๋ฐ์žˆ์–ด์„œ์–ด๋Š์ •๋„๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? 2. ์น˜๋ฃŒํšจ๊ณผ๊ฐ€๋‚˜ํƒ€๋‚˜๋Š”๋ฐ๊นŒ์ง€๊ฑธ๋ฆฌ๋Š”์‹œ๊ฐ„์—์–ด๋Š์ •๋„๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? 3. ๊ท€ํ•˜๊ฐ€๊ธฐ๋Œ€ํ–ˆ๋˜๋ฐ”์—๋น„ํ•˜์—ฌ์น˜๋ฃŒํšจ๊ณผ์—์–ด๋Š์ •๋„๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? Extremely dissatisfied ์™„์ „๋ถˆ๋งŒ์กฑ ์•„์ฃผ๋งค์šฐ๋ถˆ๋งŒ์กฑ์Šค๋Ÿฝ๋‹ค ์ง€๊ทนํžˆ๋ถˆ๋งŒ์กฑ Very dissatisfied ๋งค์šฐ๋งŒ์กฑ ์•„์ฃผ๋ถˆ๋งŒ์กฑ์Šค๋Ÿฝ๋‹ค ๋งค์šฐ๋ถˆ๋งŒ์กฑ Dissatisfied ๋ถˆ๋งŒ์กฑ ๋ถˆ๋งŒ์กฑ์Šค๋Ÿฝ๋‹ค ๋ถˆ๋งŒ์กฑ Satisfied ๋งŒ์กฑ ๋งŒ์กฑ์Šค๋Ÿฝ๋‹ค ๋งŒ์กฑ Very satisfied ๋งค์šฐ๋งŒ์กฑ ์•„์ฃผ๋งŒ์กฑ์Šค๋Ÿฝ๋‹ค ๋งค์šฐ๋งŒ์กฑ Extremely satisfied ์™„์ „๋งŒ์กฑ ์•„์ฃผ๋งค์šฐ๋งŒ์กฑ์Šค๋Ÿฝ๋‹ค ์ง€๊ทนํžˆ๋งŒ์กฑ 4. How convenient or inconvenient is it to take the treatment as instructed? 4. ์„ค๋ช…์ง€์—๋ช…์‹œ๋œ๋Œ€๋กœ์น˜๋ฃŒ๋ฅผ๋ฐ›๋Š”๊ฒƒ์ด์–ผ๋งˆ๋‚˜์šฉ์ดํ˜น์€๋ถˆํŽธํ•˜์‹ญ๋‹ˆ๊นŒ? 4. ์„ค๋ช…์„œ๋Œ€๋กœ์น˜๋ฃŒ๋ฅผ๋ฐ›์œผ์‹œ๋Š”๊ฒƒ์ด์–ด๋Š์ •๋„ํŽธํ•˜์‹œ๊ฑฐ๋‚˜๋ถˆํŽธํ•˜์‹ ๊ฐ€์š”? 4. ๊ท€ํ•˜๊ฐ€์น˜๋ฃŒ๋ฅผ๋ฐ›๋Š”๋ฐ์–ด๋Š์ •๋„ํŽธ๋ฆฌํ˜น์€๋ถˆํŽธํ•˜์…จ์Šต๋‹ˆ๊นŒ? Extremely inconvenient ์™„์ „๋ถˆํŽธํ•จ ์•„์ฃผ๋งค์šฐ๋ถˆํŽธํ•˜๋‹ค ์ง€๊ทนํžˆ๋ถˆํŽธํ•จ Very inconvenient ๋งค์šฐ๋ถˆํŽธํ•จ ์•„์ฃผ๋ถˆํŽธํ•˜๋‹ค ๋งค์šฐ๋ถˆํŽธํ•จ Inconvenient ๋ถˆํŽธํ•จ ๋ถˆํŽธํ•˜๋‹ค ๋ถˆํŽธํ•จ Convenient ์šฉ์ดํ•จ ํŽธํ•˜๋‹ค ํŽธ๋ฆฌํ•จ Very convenient ๋งค์šฐ์šฉ์ดํ•จ ์•„์ฃผํŽธํ•˜๋‹ค ๋งค์šฐํŽธ๋ฆฌํ•จ Extremely convenient ์™„์ „์šฉ์ดํ•จ ์•„์ฃผ๋งค์šฐํŽธํ•˜๋‹ค ์ง€๊ทนํžˆํŽธ๋ฆฌํ•จ 5. How often did you experience side effects from your treatment? 5. ๊ท€ํ•˜๋Š”์–ผ๋งˆ๋‚˜์ž์ฃผ์น˜๋ฃŒ์— 5. ๊ท€ํ•˜๊ป˜์„œ๋Š”์–ผ๋งˆ๋‚˜์ž์ฃผ์น˜์˜ํ•œ๋ถ€์ž‘์šฉ์„๊ฒฝํ—˜ํ•˜์…จ์Šต๋ฃŒ๋ถ€์ž‘์šฉ์„๊ฒฝํ—˜ํ•˜์‹œ๋‚˜์š”? ๋‹ˆ๊นŒ? Never ๋ถ€์ž‘์šฉ๊ฒฝํ—˜์—†์Œ ํ•œ๋ฒˆ๋„์—†๋‹ค ์ „ํ˜€์—†์Œ A little of the time ๋งค์šฐ๊ฐ€๋” ๊ฑฐ์˜์—†๋‹ค ๊ฑฐ์˜์—†์Œ 5. ๊ท€ํ•˜๋Š”์–ผ๋งˆ๋‚˜์ž์ฃผ์น˜๋ฃŒ๋ถ€์ž‘์šฉ์„๊ฒฝํ—˜ํ•˜์…จ์Šต๋‹ˆ๊นŒ? (Continued to the next page) 312 www.einj.org

Lee, et al. Linguistic Validation of TS-VAS and OAB-SAT-q INJ Table 2. Continued US English item First forward Korean translation (Translation 1) Second forward Korean translation (Translation 2) Some of the time ๊ฐ€๋”๊ฐ€๋”์žˆ๋‹ค๊ฐ€๋”์žˆ์Œ Reconciled forward Korean translation A good bit of time ์ž์ฃผ๊ทธ๋Ÿฐ์ ์ด์—ฌ๋Ÿฌ๋ฒˆ์žˆ๋‹ค์ƒ๋‹นํžˆ์žˆ์Œ Most of time ๋งค์šฐ์ž์ฃผ๊ฒฝํ—˜ํ•จ๊ฑฐ์˜์žˆ๋‹ค๋งค์šฐ์ž์ฃผ์žˆ์Œ All of the time ํ•ญ์ƒํ•ญ์ƒ์žˆ๋‹คํ•ญ์ƒ์žˆ์Œ 6. How bothersome are the side effects of the treatment you take to treat your overactive bladder? 6. ๊ท€ํ•˜์˜๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ์—์˜ํ•œ๋ถ€์ž‘์šฉ์ด์–ผ๋งˆ๋‚˜๋ถˆํŽธํ•˜์‹ญ๋‹ˆ๊นŒ? 6. ๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์„์น˜๋ฃŒํ•˜๋Š”๋ฐ์žˆ์–ด์„œ๋ถ€์ž‘์šฉ์ด๊ท€ํ•˜๊ป˜์–ด๋Š์ •๋„์˜๋ถˆํŽธํ•จ์„์ฃผ๋‚˜์š”? 6. ๊ท€ํ•˜๋Š”๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ๋ฅผ๋ฐ›๋Š”๋ฐ์žˆ์–ด์„œ ( ์น˜๋ฃŒ ) ๋ถ€์ž‘์šฉ์ด์–ผ๋งˆ๋‚˜๋ถˆํŽธํ•˜์‹ญ๋‹ˆ๊นŒ? Extremely bothersome ์™„์ „ํžˆ๋ถˆํŽธํ•จ ์•„์ฃผ๋งค์šฐ๋ถˆํŽธํ•˜๋‹ค ์ง€๊ทนํžˆ๋ถˆํŽธํ•จ Very bothersome ๋งค์šฐ๋ถˆํŽธํ•จ ๋งŽ์ด๋ถˆํŽธํ•˜๋‹ค ๋งค์šฐ๋ถˆํŽธํ•จ Somewhat bothersome ์ ๋‹นํžˆ๋ถˆํŽธํ•จ ์–ด๋Š์ •๋„๋ถˆํŽธํ•˜๋‹ค ๋‹ค์†Œ๋ถˆํŽธํ•จ A little bothersome ์•ฝ๊ฐ„๋ถˆํŽธํ•จ ์กฐ๊ธˆ๋ถˆํŽธํ•˜๋‹ค ์•ฝ๊ฐ„๋ถˆํŽธํ•จ Not at all bothersome ์ „ํ˜€๋ถˆํŽธํ•˜์ง€์•Š์Œ ์ „ํ˜€๋ถˆํŽธํ•˜์ง€์•Š๋‹ค ์ „ํ˜€๋ถˆํŽธํ•˜์ง€์•Š์Œ 7. To what degree have side effects affected your overall satisfaction with the treatment? 7. ๋ถ€์ž‘์šฉ์ด๊ท€ํ•˜์˜์ „๋ฐ˜์ ์ธ 7. ๋ถ€์ž‘์šฉ์ด๊ท€ํ•˜์˜์ „์ฒด์ ์ธ 7. ๊ท€ํ•˜์˜์ „๋ฐ˜์ ์ธ์น˜๋ฃŒ๋งŒ ์น˜๋ฃŒ๋งŒ์กฑ๋„์—์–ผ๋งˆ๋‚˜์˜ํ–ฅ์„๋ฏธ์ณค์Šต๋‹ˆ๊นŒ? ์น˜๋ฃŒ๋ฒ•๋งŒ์กฑ๋„์—์–ด๋Š์ •๋„์˜์˜ํ–ฅ์„์ฃผ์—ˆ๋‚˜์š”? ์กฑ๋„์—๋ถ€์ž‘์šฉ์ด์–ผ๋งˆ๋‚˜์˜ํ–ฅ์„๋ฏธ์ณค์Šต๋‹ˆ๊นŒ? A great deal ๋งค์šฐ๋งŽ์ด ์ƒ๋‹นํžˆ๋งŽ์ด์ฃผ์—ˆ์Šต๋‹ˆ๋‹ค ์ƒ๋‹นํžˆ๋งŽ์ด Quite a bit ์ƒ๋‹นํžˆ / ์ ๋‹นํžˆ ์ƒ๋‹นํžˆ์ฃผ์—ˆ์Šต๋‹ˆ๋‹ค ๊ฝค๋งŽ์ด Somewhat ์•ฝ๊ฐ„์ ๊ฒŒ ์–ด๋Š์ •๋„์ฃผ์—ˆ์Šต๋‹ˆ๋‹ค ๋‹ค์†Œ Minimally ๋งค์šฐ์ ๊ฒŒ ์ตœ์†Œ์ฃผ์—ˆ์Šต๋‹ˆ๋‹ค ๊ทนํžˆ์ผ๋ถ€๋ถ„ Not at all ์ „ํ˜€์˜ํ–ฅ์—†์Œ ์ „ํ˜€์ฃผ์ง€์•Š์•˜์Šต๋‹ˆ๋‹ค ์ „ํ˜€์˜ํ–ฅ์—†์Œ 8. Do you prefer the treatment that you received since entering this study to the treatment you received before the study? Never been treated before for overactive bladder Definitely prefer my previous treatment Slight preference for my previous treatment Slight preference for the treatment I am receiving now Definitely prefer the treatment I am receiving now 9. Would you be willing to use the same treatment for your bladder problem that you have received since entering this study? 8. ๊ท€ํ•˜๊ฐ€์‹คํ—˜์ฐธ๊ฐ€ํ›„์—๋ฐ›์œผ์‹ ์น˜๋ฃŒ๋ฅผ์‹คํ—˜์ฐธ๊ฐ€์ „์—๋ฐ›์œผ์‹ ์น˜๋ฃŒ๋ณด๋‹ค์„ ํ˜ธํ•˜์‹ญ๋‹ˆ๊นŒ? ๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ๋ฅผ๋ฐ›์•„๋ณธ์ ์ด์—†์Œ ์‹คํ—˜์ฐธ๊ฐ€์ „์—๋ฐ›์€์น˜๋ฃŒ๋ฅผํ™•์‹คํ•˜๊ฒŒ์„ ํ˜ธํ•จ์‹คํ—˜์ฐธ๊ฐ€์ „์—๋ฐ›์€์น˜๋ฃŒ๋ฅผ์•ฝ๊ฐ„์„ ํ˜ธํ•จ์‹คํ—˜์ฐธ๊ฐ€ํ›„์—๋ฐ›์€์น˜๋ฃŒ๋ฅผ์•ฝ๊ฐ„์„ ํ˜ธํ•จ์‹คํ—˜์ฐธ๊ฐ€ํ›„์—๋ฐ›์€์น˜๋ฃŒ๋ฅผํ™•์‹คํ•˜๊ฒŒ์„ ํ˜ธํ•จ 9. ๊ท€ํ•˜์˜๋ฐฉ๊ด‘๋ฌธ์ œ๋ฅผ์น˜๋ฃŒํ•˜๊ธฐ์œ„ํ•ด์‹คํ—˜์ฐธ๊ฐ€ํ›„์—๋ฐ›์œผ์‹ ๊ฑฐ์™€๋™์ผํ•œ์น˜๋ฃŒ๋ฅผ๋ฐ›๊ธฐ๋ฅผ์›ํ•˜์‹ญ๋‹ˆ๊นŒ? Definitely would not use the same treatment again ํ™•์‹คํžˆ๊ฐ™์€์น˜๋ฃŒ๋ฅผ๋ฐ›๊ณ ์‹ถ์ง€์•Š์Œ Might not use the same treatment again ๊ฐ™์€์น˜๋ฃŒ๋ฅผ๋‹ค์‹œ์„ ํƒํ•˜์ง€์•Š์„์ˆ˜๋„์žˆ์Œ 8. ๊ท€ํ•˜๊ป˜์„œ๋Š”์ด๋ฒˆ์—ฐ๊ตฌ์—์„œ๋ฐ›์œผ์‹ ์น˜๋ฃŒ๋ฒ•์„์ด์ „์—๋ฐ›์œผ์…จ๋˜์น˜๋ฃŒ๋ฒ•๋ณด๋‹ค๋”์„ ํ˜ธํ•˜์‹ญ๋‹ˆ๊นŒ? ์ด๋ฒˆ์—ฐ๊ตฌ์ด์ „์—๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ๋ฅผ๋ฐ›์€์ด๋ ฅ์ด์ „ํ˜€์—†์Šต๋‹ˆ๋‹ค๋ถ„๋ช…ํžˆ์ด๋ฒˆ์—ฐ๊ตฌ์ด์ „์—๋ฐ›์€์น˜๋ฃŒ๋ฒ•์„์„ ํ˜ธํ•ฉ๋‹ˆ๋‹ค์ด๋ฒˆ์—ฐ๊ตฌ์ด์ „์—๋ฐ›์€์น˜๋ฃŒ๋ฒ•์„์กฐ๊ธˆ๋”์„ ํ˜ธํ•ฉ๋‹ˆ๋‹ค์ด๋ฒˆ์—ฐ๊ตฌ์˜์น˜๋ฃŒ๋ฒ•์„์กฐ๊ธˆ๋”์„ ํ˜ธํ•ฉ๋‹ˆ๋‹ค๋ถ„๋ช…ํžˆ์ด๋ฒˆ์—ฐ๊ตฌ์˜์น˜๋ฃŒ๋ฒ•์„์„ ํ˜ธํ•ฉ๋‹ˆ๋‹ค 9. ๊ท€ํ•˜๊ป˜์„œ๋Š”๋ฐฉ๊ด‘๋ฌธ์ œ์น˜๋ฃŒ๋ฐฉ๋ฒ•์œผ๋กœ์ด๋ฒˆ์—ฐ๊ตฌ์—์„œ๋ฐ›์œผ์‹ ์น˜๋ฃŒ๋ฒ•๊ณผ๋™์ผํ•œ์น˜๋ฃŒ๋ฒ•์„์‚ฌ์šฉํ•˜์‹œ๊ฒ ์Šต๋‹ˆ๊นŒ? ์ ˆ๋Œ€๋กœ๋™์ผํ•œ์น˜๋ฃŒ๋ฒ•์„์‚ฌ์šฉํ•˜์ง€์•Š์„๊ฒƒ์ด๋‹ค์•„๋งˆ๋„๋™์ผํ•œ์น˜๋ฃŒ๋ฒ•์„์‚ฌ์šฉํ•˜์ง€์•Š์„๊ฒƒ์ด๋‹ค 8. ๊ท€ํ•˜๋Š”์ด์ „์—๋ฐ›์•˜๋˜์น˜๋ฃŒ๋ฐฉ๋ฒ•๋ณด๋‹ค์ด๋ฒˆ์—ฐ๊ตฌ์—์„œ๋ฐ›์€์น˜๋ฃŒ๋ฐฉ๋ฒ•์„๋”์„ ํ˜ธํ•˜์‹ญ๋‹ˆ๊นŒ? ๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ๋ฅผ๋ฐ›์•„๋ณธ์ ์ด์—†์Œ ์ด์ „์—๋ฐ›์€์น˜๋ฃŒ๋ฅผ๋ถ„๋ช…ํžˆ์„ ํ˜ธํ•จ์ด์ „์—๋ฐ›์€์น˜๋ฃŒ๋ฅผ์•ฝ๊ฐ„์„ ํ˜ธํ•จ์ด๋ฒˆ์—ฐ๊ตฌ์˜์น˜๋ฃŒ๋ฐฉ๋ฒ•์„์•ฝ๊ฐ„์„ ํ˜ธํ•จ์ด๋ฒˆ์—ฐ๊ตฌ์˜์น˜๋ฃŒ๋ฐฉ๋ฒ•์„๋ถ„๋ช…ํžˆ์„ ํ˜ธํ•จ 9. ๊ท€ํ•˜๋Š”๋ฐฉ๊ด‘๋ฌธ์ œ๋ฅผ์น˜๋ฃŒํ•˜๊ธฐ์œ„ํ•ด์ด๋ฒˆ์—ฐ๊ตฌ์—์„œ๋ฐ›์€์น˜๋ฃŒ๋ฐฉ๋ฒ•๊ณผ๋™์ผํ•œ์น˜๋ฃŒ๋ฅผ๋ฐ›์„์˜ํ–ฅ์ด์žˆ์œผ์‹ญ๋‹ˆ๊นŒ? ๋™์ผํ•œ์น˜๋ฃŒ๋ฐฉ๋ฒ•์„๋ถ„๋ช…ํžˆ๋ฐ›์ง€์•Š์„๊ฒƒ์ž„๋™์ผํ•œ์น˜๋ฃŒ๋ฐฉ๋ฒ•์„์•„๋งˆ๋„๋ฐ›์ง€์•Š์„๊ฒƒ์ž„ (Continued to the next page) www.einj.org 313

INJ Lee, et al. Linguistic Validation of TS-VAS and OAB-SAT-q Table 2. Continued US English item Might use the same treatment again Definitely would use the same treatment again 10. Would you recommend this treatment to others with overactive bladder? First forward Korean translation (Translation 1) ๊ฐ™์€์น˜๋ฃŒ๋ฅผ๋‹ค์‹œ์„ ํƒํ• ์ˆ˜๋„์žˆ์Œํ™•์‹คํžˆ๊ฐ™์€์น˜๋ฃŒ๋ฅผ๋‹ค์‹œ๋ฐ›๊ณ ์‹ถ์Œ 10. ๊ท€ํ•˜๊ฐ€๋ฐ›๊ณ ๊ณ„์‹ ์น˜๋ฃŒ๋ฅผ๋‹ค๋ฅธ๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘ํ™˜์ž๋“ค์—๊ฒŒ์ถ”์ฒœํ•˜์‹œ๊ฒ ์Šต๋‹ˆ๊นŒ? Second forward Korean translation (Translation 2) ์•„๋งˆ๋„๋™์ผํ•œ์น˜๋ฃŒ๋ฒ•์„์‚ฌ์šฉํ• ๊ฒƒ์ด๋‹ค๋ถ„๋ช…ํžˆ๋™์ผํ•œ์น˜๋ฃŒ๋ฒ•์„์‚ฌ์šฉํ• ๊ฒƒ์ด๋‹ค 10. ๊ท€ํ•˜๊ป˜์„œ๋Š”๋‹ค๋ฅธ๋ถ„์—๊ฒŒ๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ๋ฐฉ๋ฒ•์œผ๋กœ์ด์น˜๋ฃŒ๋ฒ•์„์ถ”์ฒœํ•˜์‹œ๊ฒ ์Šต๋‹ˆ๊นŒ? Reconciled forward Korean translation ๋™์ผํ•œ์น˜๋ฃŒ๋ฐฉ๋ฒ•์„๋ฐ›์„์ˆ˜๋„์žˆ์Œ๋™์ผํ•œ์น˜๋ฃŒ๋ฐฉ๋ฒ•์„๋ถ„๋ช…ํžˆ๋ฐ›์„๊ฒƒ์ž„ 10. ๊ท€ํ•˜๋Š”๋‹ค๋ฅธ๋ถ„์—๊ฒŒ๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ๋ฐฉ๋ฒ•์œผ๋กœ์ด์น˜๋ฃŒ๋ฐฉ๋ฒ•์„์ถ”์ฒœํ•˜์‹œ๊ฒ ์Šต๋‹ˆ๊นŒ? Definitely would not recommend ์ถ”์ฒœํ•˜์ง€์•Š์„๊ฒƒ์ดํ™•์‹คํ•จ ์ ˆ๋Œ€๋กœ์ถ”์ฒœํ•˜์ง€์•Š์„๊ฒƒ์ด๋‹ค ์ ˆ๋Œ€๋กœ์ถ”์ฒœํ•˜์ง€์•Š์„๊ฒƒ์ž„ Might not recommend ์ถ”์ฒœํ•˜์ง€์•Š์„์ˆ˜๋„์žˆ์Œ ์•„๋งˆ๋„์ถ”์ฒœํ•˜์ง€์•Š์„๊ฒƒ์ด๋‹ค ์•„๋งˆ๋„์ถ”์ฒœํ•˜์ง€์•Š์„๊ฒƒ์ž„ Might recommend ์ถ”์ฒœํ• ์ˆ˜๋„์žˆ์Œ ์•„๋งˆ๋„์ถ”์ฒœํ• ๊ฒƒ์ด๋‹ค ์ถ”์ฒœํ• ์ˆ˜๋„์žˆ์Œ Definitely would recommend ์ถ”์ฒœํ• ๊ฒƒ์ดํ™•์‹คํ•จ ๋ถ„๋ช…ํžˆ์ถ”์ฒœํ• ๊ฒƒ์ด๋‹ค ๋ถ„๋ช…ํžˆ์ถ”์ฒœํ• ๊ฒƒ์ž„ 11. Overall, how satisfied or dissatisfied are you with this treatment? 11. ์ „๋ฐ˜์ ์œผ๋กœ๊ท€ํ•˜๋Š”๊ท€ํ•˜์˜ 11. ์ „์ฒด์ ์œผ๋กœ์ด์น˜๋ฃŒ๋ฒ•์— 11. ์ „๋ฐ˜์ ์œผ๋กœ๊ท€ํ•˜์˜์น˜ ์น˜๋ฃŒ์—์–ผ๋งˆ๋‚˜๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? ๋Œ€ํ•ด์–ด๋Š์ •๋„๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? ๋ฃŒ์—์–ผ๋งˆ๋‚˜๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? Extremely dissatisfied ์™„์ „๋ถˆ๋งŒ์กฑ ์•„์ฃผ๋งค์šฐ๋ถˆ๋งŒ์กฑ์Šค๋Ÿฝ๋‹ค ์ง€๊ทนํžˆ๋ถˆ๋งŒ์กฑ Very dissatisfied ๋งค์šฐ๋ถˆ๋งŒ์กฑ ์•„์ฃผ๋ถˆ๋งŒ์กฑ์Šค๋Ÿฝ๋‹ค ๋งค์šฐ๋ถˆ๋งŒ์กฑ Dissatisfied ๋ถˆ๋งŒ์กฑ ๋ถˆ๋งŒ์กฑ์Šค๋Ÿฝ๋‹ค ๋ถˆ๋งŒ์กฑ Satisfied ๋งŒ์กฑ ๋งŒ์กฑ์Šค๋Ÿฝ๋‹ค ๋งŒ์กฑ Very satisfied ๋งค์šฐ๋งŒ์กฑ ์•„์ฃผ๋งŒ์กฑ์Šค๋Ÿฝ๋‹ค ๋งค์šฐ๋งŒ์กฑ Extremely satisfied ์™„์ „๋งŒ์กฑ ์•„์ฃผ๋งค์šฐ๋งŒ์กฑ์Šค๋Ÿฝ๋‹ค ์ง€๊ทนํžˆ๋งŒ์กฑ some are the side effects of the treatment you take to treat your overactive bladder? in the original version, was translated as gwihaneun gwaminseong banggwang chiryoreul banneundeisseoseo chiryobujagyongi eolmana bulpyeonhasimnikka? The responses included phrases such as extremely bothersome, very bothersome, somewhat bothersome, a little bothersome, and not at all bothersome, which were translated as follows after the panel discussed the translation possibilities: jigeuki bulpyeonham, maeu bulpyeonham, daso bulpyeonham, yakgan bulpyeonham, and jeonhyeo bulpyeonhaji aneum, respectively. Question 7, To what degree have side effects affected your overall satisfaction with treatment? in the original version, was directly translated as jeonbanjeogin chiryo manjokdoe bujagyongi eolmana yeonghyangeul michyeotseumnikka? The translation of this question did not meaningfully differ between the 2 translators. Question 8, Do you prefer the treatment that you received since entering this study to the treatment you received before the study? in the original version, was directly translated as ibeon yeongueseobadeun chiryobangbeobeul deo seonhohasimnikka? Question 9, Would you be willing to use the same treatment for your bladder problem that you have received since entering this study? in the original version, was directly translated as dongilhan chiryoreul badeul uihyangi isseusimnikka? ( Would you be willing to use the same treatment? ) The panel discussed and reconciled the 2 different translated sentences into the final question, and included uihyang ( willing ). Question 10, Would you recommend this treatment to others with overactive bladder? in the original version, was directly translated as ichiryobangbeobeul chucheon hasigetseumnikka? ( Would you recommend this treatment to others? ). Question 11, Overall, how satisfied or dissatisfied are you with this treatment? in the original version, was directly translated as jeonbanjeogeuro gwihaui chiryoeeol manamanjok hogeun bulmanjokasimnikka? The panel attempted to choose sentences that preserved the exact meaning of the English phrases, and reconciled the 2 translated versions to provide more natural expressions in the Korean language, within the framework of conceptual equivalence. The panel chose the final forward-translated versions on this basis. Backward Translation As shown in Table 3, the panel agreed that there were no signif- 314 www.einj.org

Lee, et al. Linguistic Validation of TS-VAS and OAB-SAT-q INJ Table 3. Backward translation Original Forward translation Back translation TS-VAS Please place a vertical mark on the line to indicate your answer to the question below ์น˜๋ฃŒ๋งŒ์กฑ๋„์‹œ๊ฐ์ ์ฒ™๋„ ๋‹ค์Œ์งˆ๋ฌธ์„๋‹ตํ•˜๊ธฐ์œ„ํ•ด์„ ์œ„์—์„ธ๋กœ์„ ์„ํ‘œ๊ธฐํ•ด์ฃผ์‹œ๊ธฐ๋ฐ”๋ž๋‹ˆ๋‹ค. I n order to answer the following question, please indicate a vertical line on the line Are you satisfied with your treatment? ๊ท€ํ•˜๋Š”์น˜๋ฃŒ์—๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? Are you satisfied with your treatment? No, not at all ์•„๋‹ˆ์š”, ์ „ํ˜€๊ทธ๋ ‡์ง€์•Š์Œ No, I do not feel satisfied at all. Yes, completely ๋„ค, ์ „์ ์œผ๋กœ๋งŒ์กฑํ•จ Yes, I am fully satisfied. OAB-SAT-q ๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ๋งŒ์กฑ๋„์„ค๋ฌธ์ง€ The satisfaction of overactive bladder treatment Instructions: ์ง€์‹œ์‚ฌํ•ญ : Explanation/Description: P lease think about how satisfied you have been ๊ท€ํ•˜๋Š”์ด๋ฒˆ์—ฐ๊ตฌ์—์„œ๋ฐ›์€์น˜๋ฃŒ์—์–ด๋Š์ •๋„๋งŒ with the treatment you have received in the ์กฑํ•˜๋Š”์ง€์ƒ๊ฐํ•ด๋ณด์‹œ๊ธฐ๋ฐ”๋ž๋‹ˆ๋‹ค. study. The questions below will ask you to rate how satisfied or dissatisfied you are with your treat- ๋„๋งŒ์กฑ๋˜๋Š”๋ถˆ๋งŒ์กฑํ•˜๋Š”์ง€๋ฅผํ‰๊ฐ€ํ• ๊ฒƒ์ž…๋‹ˆ๋‹ค. ์•„๋ž˜์˜์งˆ๋ฌธ๋“ค์€๊ท€ํ•˜๊ฐ€๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ์—์–ด๋Š์ • ment for overactive bladder. P lease think how satisfied you are with treatment you have received during this investigation T he questions below will evaluate either how satisfied or dissatisfied you were with the overactive bladder treatment Thinking about the past four weeks, check one ์ง€๋‚œ 4์ฃผ๋™์•ˆ, ๊ท€ํ•˜์˜์น˜๋ฃŒ๊ฒฝํ—˜์„๊ฐ€์žฅ์ •ํ™•ํ•˜ Please indicate the box that best describes your box for each item that best reflects your treatment experience. each ๊ฒŒ๋ฐ˜์˜ํ•˜๋Š”์นธ์„ํ•ญ๋ชฉ๋ณ„๋กœํ‘œ์‹œํ•˜์—ฌ์ฃผ์‹ญ์‹œ์˜ค. treatment experience during the past 4 weeks in category 1. How satisfied or dissatisfied are you with the way the treatment relieves your symptoms? 1. ์น˜๋ฃŒ๊ฐ€๊ท€ํ•˜์˜์ฆ์ƒ์„์™„ํ™”์‹œํ‚ค๋Š”๋ฐ์žˆ์–ด์„œ์–ด๋Š์ •๋„๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? 2. How satisfied or dissatisfied are you with the 2. ์น˜๋ฃŒํšจ๊ณผ๊ฐ€๋‚˜ํƒ€๋‚˜๋Š”๋ฐ๊นŒ์ง€๊ฑธ๋ฆฌ๋Š”์‹œ๊ฐ„์— amount of time it takes the treatment to start ์–ด๋Š์ •๋„๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? working? 3. How satisfied or dissatisfied are you with the 3. ๊ท€ํ•˜๊ฐ€๊ธฐ๋Œ€ํ–ˆ๋˜๋ฐ”์—๋น„ํ•˜์—ฌ์น˜๋ฃŒํšจ๊ณผ์—์–ด effectiveness of the treatment, compared to ๋Š์ •๋„๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? what you expected? 1. How satisfied or dissatisfied are you with treatment relieving your symptoms? 2. How satisfied or dissatisfied are you with the time that it takes to show the effect of the treatment 3. Compared to your expectations, how satisfied or dissatisfied are you with the effect of the treatment? Extremely dissatisfied ์ง€๊ทนํžˆ๋ถˆ๋งŒ์กฑ Extremely dissatisfied Very dissatisfied ๋งค์šฐ๋ถˆ๋งŒ์กฑ Very dissatisfied Dissatisfied ๋ถˆ๋งŒ์กฑ Dissatisfied Satisfied ๋งŒ์กฑ Satisfied Very satisfied ๋งค์šฐ๋งŒ์กฑ Very satisfied Extremely satisfied ์ง€๊ทนํžˆ๋งŒ์กฑ Fully Satisfied 4. How convenient or inconvenient is it to take the treatment as instructed? 4. ๊ท€ํ•˜๊ฐ€์น˜๋ฃŒ๋ฅผ๋ฐ›๋Š”๋ฐ์–ด๋Š์ •๋„ํŽธ๋ฆฌํ˜น์€๋ถˆํŽธํ•˜์…จ์Šต๋‹ˆ๊นŒ? 4. How comfortable or uncomfortable are you with receiving treatments the way you have been explained Extremely inconvenient ์ง€๊ทนํžˆ๋ถˆํŽธํ•จ Extremely uncomfortable Very inconvenient ๋งค์šฐ๋ถˆํŽธํ•จ Very uncomfortable Inconvenient ๋ถˆํŽธํ•จ Uncomfortable Convenient ํŽธ๋ฆฌํ•จ Convenient Very convenient ๋งค์šฐํŽธ๋ฆฌํ•จ Very convenient Extremely convenient ์ง€๊ทนํžˆํŽธ๋ฆฌํ•จ Exceptionally convenient 5. How often did you experience side effects from your treatment? 5. ๊ท€ํ•˜๋Š”์–ผ๋งˆ๋‚˜์ž์ฃผ์น˜๋ฃŒ๋ถ€์ž‘์šฉ์„๊ฒฝํ—˜ํ•˜์…จ์Šต๋‹ˆ๊นŒ? Never ์ „ํ˜€์—†์Œ Never A little of the time ๊ฑฐ์˜์—†์Œ Seldom/rarely 5. How often have you experienced the side effects (of the treatment)? (Continued to the next page) www.einj.org 315

INJ Lee, et al. Linguistic Validation of TS-VAS and OAB-SAT-q Table 3. Continued Original Forward translation Back translation Some of the time ๊ฐ€๋”์žˆ์Œ Occasionally A good bit of time ์ƒ๋‹นํžˆ์žˆ์Œ Quite often Most of time ๋งค์šฐ์ž์ฃผ์žˆ์Œ Very often All of the time ํ•ญ์ƒ์žˆ์Œ All of the time 6. How bothersome are the side effects of the 6. ๊ท€ํ•˜๋Š”๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ๋ฅผ๋ฐ›๋Š”๋ฐ์žˆ์–ด์„œ ( ์น˜ treatment you take to treat your overactive ๋ฃŒ ) ๋ถ€์ž‘์šฉ์ด์–ผ๋งˆ๋‚˜๋ถˆํŽธํ•˜์‹ญ๋‹ˆ๊นŒ? bladder? 7. To what degree have side effects affected your overall satisfaction with treatment? 7. ๊ท€ํ•˜์˜์ „๋ฐ˜์ ์ธ์น˜๋ฃŒ๋งŒ์กฑ๋„์—๋ถ€์ž‘์šฉ์ด์–ผ๋งˆ๋‚˜์˜ํ–ฅ์„๋ฏธ์ณค์Šต๋‹ˆ๊นŒ? 6. How uncomfortable are you with the side effects from/when receiving the overactive bladder treatment 7. To what extent did the side effects influence the overall satisfaction of the treatment A great deal ์ƒ๋‹นํžˆ๋งŽ์ด To a very large extent Quite a bit ๊ฝค๋งŽ์ด To a large extent Somewhat ๋‹ค์†Œ To some extent Minimally ๊ทนํžˆ์ผ๋ถ€๋ถ„ To a very small extent Not at all ์ „ํ˜€์˜ํ–ฅ์—†์Œ No influence at all 8. Do you prefer the treatment that you received 8. ๊ท€ํ•˜๋Š”์ด์ „์—๋ฐ›์•˜๋˜์น˜๋ฃŒ๋ฐฉ๋ฒ•๋ณด๋‹ค์ด๋ฒˆ์—ฐ๊ตฌ 8. Do you prefer this treatment (method) rather since entering this study to the treatment you received before the study? ์—์„œ๋ฐ›์€์น˜๋ฃŒ๋ฐฉ๋ฒ•์„๋”์„ ํ˜ธํ•˜์‹ญ๋‹ˆ๊นŒ? than the previous treatment (method)? 9. Would you be willing to use the same treatment for your bladder problem that you have received since entering this study? 10. Would you recommend this treatment to others with overactive bladder? 11. Overall, how satisfied or dissatisfied are you with this treatment? 9. ๊ท€ํ•˜๋Š”๋ฐฉ๊ด‘๋ฌธ์ œ๋ฅผ์น˜๋ฃŒํ•˜๊ธฐ์œ„ํ•ด์ด๋ฒˆ์—ฐ๊ตฌ 9. Do you have any intentions to receive the ์—์„œ๋ฐ›์€์น˜๋ฃŒ๋ฐฉ๋ฒ•๊ณผ๋™์ผํ•œ์น˜๋ฃŒ๋ฅผ๋ฐ›์„์˜ same type/method of treatment as the previous one to treat the bladder ํ–ฅ์ด์žˆ์œผ์‹ญ๋‹ˆ๊นŒ? problems? 10. ๊ท€ํ•˜๋Š”๋‹ค๋ฅธ๋ถ„์—๊ฒŒ๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ๋ฐฉ๋ฒ•์œผ๋กœ์ด์น˜๋ฃŒ๋ฐฉ๋ฒ•์„์ถ”์ฒœํ•˜์‹œ๊ฒ ์Šต๋‹ˆ๊นŒ? 11. ์ „๋ฐ˜์ ์œผ๋กœ๊ท€ํ•˜์˜์น˜๋ฃŒ์—์–ผ๋งˆ๋‚˜๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? 10. Would you recommend this overactive bladder treatment (method) to other people? 11. How satisfied or dissatisfied are you with your treatment overall? TS-VAS, Treatment Satisfaction Visual Analogue Scale; OAB-SAT-q, Overactive Bladder Satisfaction with Treatment Questionnaire. icant differences between the wording of the sentences in the original and the back-translated versions. ์น˜๋ฃŒ๋งŒ์กฑ๋„์‹œ๊ฐ์ ์ฒ™๋„ (TS-VAS) ๋‹ค์Œ์งˆ๋ฌธ์„๋‹ตํ•˜๊ธฐ์œ„ํ•ด์„ ์œ„์—์„ธ๋กœ์„ ์„ํ‘œ๊ธฐํ•ด์ฃผ์‹œ๊ธฐ๋ฐ”๋ž๋‹ˆ๋‹ค. ๊ท€ํ•˜๋Š”์น˜๋ฃŒ์—๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? ์•„๋‹ˆ์š”, ์ „ํ˜€๊ทธ๋ ‡์ง€์•Š์Œ. ๋„ค, ์ „์ ์œผ๋กœ๋งŒ์กฑํ•จ. Fig. 1. Korean version of the Treatment Satisfaction Visual Analogue Scale (TS-VAS). Cognitive Debriefing and Proofreading The translation was tested by 5 patients with OAB (3 men and 2 women; age range, 30 70 years) who underwent medical therapy. Their levels of education varied from being a high school graduate to a university graduate. All patients completed the questionnaires within 8 minutes. One patient reported being unsure about the marking position on the line of TS-VAS. He suggested that vertical lines on the long horizontal line of TS- VAS could help patients understand the scale and mark their responses. The panel accepted his proposal and added 10 vertical lines indicating 0 to 10 points. Three patients reported that the translated questions were clear and easy to understand; however, 2 patients felt that the questions were a bit difficult to understand owing to the excessively long structure of the questions. The panel discussed these opinions that were articulated during the cognitive debriefing process, and the final versions of the questionnaires are shown in Figs. 1 and 2. 316 www.einj.org

Lee, et al. Linguistic Validation of TS-VAS and OAB-SAT-q INJ ๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ๋งŒ์กฑ๋„์„ค๋ฌธ์ง€ ์ง€์‹œ์‚ฌํ•ญ : ๊ท€ํ•˜๋Š”์ด๋ฒˆ์—ฐ๊ตฌ์—์„œ๋ฐ›์€์น˜๋ฃŒ์—์–ด๋Š์ •๋„๋งŒ์กฑํ•˜๋Š”์ง€์ƒ๊ฐํ•ด๋ณด์‹œ๊ธฐ๋ฐ”๋ž๋‹ˆ๋‹ค. ์•„๋ž˜์˜์งˆ๋ฌธ๋“ค์€๊ท€ํ•˜๊ฐ€๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ์—์–ด๋Š์ •๋„๋งŒ์กฑ๋˜๋Š”๋ถˆ๋งŒ์กฑํ•˜๋Š”์ง€๋ฅผํ‰๊ฐ€ํ• ๊ฒƒ์ž…๋‹ˆ๋‹ค. ์ง€๋‚œ 4 ์ฃผ๋™์•ˆ, ๊ท€ํ•˜์˜์น˜๋ฃŒ๊ฒฝํ—˜์„๊ฐ€์žฅ์ •ํ™•ํ•˜๊ฒŒ๋ฐ˜์˜ํ•˜๋Š”์นธ์„ํ•ญ๋ชฉ๋ณ„๋กœํ‘œ์‹œํ•˜์—ฌ์ฃผ์‹ญ์‹œ์˜ค. 1. ์น˜๋ฃŒ๊ฐ€๊ท€ํ•˜์˜์ฆ์ƒ์„์™„ํ™”์‹œํ‚ค๋Š”๋ฐ์žˆ์–ด์„œ์–ด๋Š์ •๋„๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? 2. ์น˜๋ฃŒํšจ๊ณผ๊ฐ€๋‚˜ํƒ€๋‚˜๋Š”๋ฐ๊นŒ์ง€๊ฑธ๋ฆฌ๋Š”์‹œ๊ฐ„์—์–ด๋Š์ •๋„๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? 3. ๊ท€ํ•˜๊ฐ€๊ธฐ๋Œ€ํ–ˆ๋˜๋ฐ”์—๋น„ํ•˜์—ฌ์น˜๋ฃŒํšจ๊ณผ์—์–ด๋Š์ •๋„๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? 4. ๊ท€ํ•˜๊ฐ€์น˜๋ฃŒ๋ฅผ๋ฐ›๋Š”๋ฐ์–ด๋Š์ •๋„ํŽธ๋ฆฌํ˜น์€๋ถˆํŽธํ•˜์…จ์Šต๋‹ˆ๊นŒ? 5. ๊ท€ํ•˜๋Š”์–ผ๋งˆ๋‚˜์ž์ฃผ์น˜๋ฃŒ๋ถ€์ž‘์šฉ์„๊ฒฝํ—˜ํ•˜์…จ์Šต๋‹ˆ๊นŒ? 6. ๊ท€ํ•˜๋Š”๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ๋ฅผ๋ฐ›๋Š”๋ฐ์žˆ์–ด์„œ ( ์น˜๋ฃŒ ) ๋ถ€์ž‘์šฉ์ด์–ผ๋งˆ๋‚˜๋ถˆํŽธํ•˜์‹ญ๋‹ˆ๊นŒ? 7. ๊ท€ํ•˜์˜์ „๋ฐ˜์ ์ธ์น˜๋ฃŒ๋งŒ์กฑ๋„์—๋ถ€์ž‘์šฉ์ด์–ผ๋งˆ๋‚˜์˜ํ–ฅ์„๋ฏธ์ณค์Šต๋‹ˆ๊นŒ? 8. ๊ท€ํ•˜๋Š”์ด์ „์—๋ฐ›์•˜๋˜์น˜๋ฃŒ๋ฐฉ๋ฒ•๋ณด๋‹ค์ด๋ฒˆ์—ฐ๊ตฌ์—์„œ๋ฐ›์€์น˜๋ฃŒ๋ฐฉ๋ฒ•์„๋”์„ ํ˜ธํ•˜์‹ญ๋‹ˆ๊นŒ? 9. ๊ท€ํ•˜๋Š”๋ฐฉ๊ด‘๋ฌธ์ œ๋ฅผ์น˜๋ฃŒํ•˜๊ธฐ์œ„ํ•ด์ด๋ฒˆ์—ฐ๊ตฌ์—์„œ๋ฐ›์€์น˜๋ฃŒ๋ฐฉ๋ฒ•๊ณผ๋™์ผํ•œ์น˜๋ฃŒ๋ฅผ๋ฐ›์„์˜ํ–ฅ์ด์žˆ์œผ์‹ญ๋‹ˆ๊นŒ? 10. ๊ท€ํ•˜๋Š”๋‹ค๋ฅธ๋ถ„์—๊ฒŒ๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ๋ฐฉ๋ฒ•์œผ๋กœ์ด์น˜๋ฃŒ๋ฐฉ๋ฒ•์„์ถ”์ฒœํ•˜์‹œ๊ฒ ์Šต๋‹ˆ๊นŒ? 11. ์ „๋ฐ˜์ ์œผ๋กœ๊ท€ํ•˜์˜์น˜๋ฃŒ์—์–ผ๋งˆ๋‚˜๋งŒ์กฑํ˜น์€๋ถˆ๋งŒ์กฑํ•˜์‹ญ๋‹ˆ๊นŒ? ์ง€๊ทนํžˆ๋ถˆ๋งŒ์กฑ ๋งค์šฐ๋ถˆ๋งŒ์กฑ ๋ถˆ๋งŒ์กฑ ๋งŒ์กฑ ๋งค์šฐ๋งŒ์กฑ ์ง€๊ทนํžˆ๋งŒ์กฑ 1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6 ์ง€๊ทนํžˆ๋ถˆํŽธํ•จ ๋งค์šฐ๋ถˆํŽธํ•จ ๋ถˆํŽธํ•จ ํŽธ๋ฆฌํ•จ ๋งค์šฐํŽธ๋ฆฌํ•จ ์ง€๊ทนํžˆํŽธ๋ฆฌํ•จ 1 2 3 4 5 6 ์ „ํ˜€์—†์Œ ๊ฑฐ์˜์—†์Œ ๊ฐ€๋”์žˆ์Œ ์ƒ๋‹นํžˆ์žˆ์Œ ๋งค์šฐ์ž์ฃผ์žˆ์Œ ํ•ญ์ƒ์žˆ์Œ 0 1 2 3 4 5 ์ „ํ˜€์—†์Œ ' ์ด๋ฉด 8๋ฒˆ๋ฌธํ•ญ์œผ๋กœ๊ฐ€์„ธ์š” ์ง€๊ทนํžˆ๋ถˆํŽธํ•จ ๋งค์šฐ๋ถˆํŽธํ•จ ๋‹ค์†Œ๋ถˆํŽธํ•จ ์•ฝ๊ฐ„๋ถˆํŽธํ•จ ์ „ํ˜€๋ถˆํŽธํ•˜์ง€ ์•Š์Œ 1 2 3 4 5 ์ƒ๋‹นํžˆ๋งŽ์ด ๊ฝค๋งŽ์ด ๋‹ค์†Œ ๊ทนํžˆ์ผ๋ถ€๋ถ„ ์ „ํ˜€์˜ํ–ฅ์—†์Œ ๊ณผ๋ฏผ์„ฑ๋ฐฉ๊ด‘์น˜๋ฃŒ๋ฅผ๋ฐ›์•„๋ณธ์ ์ด์—†์Œ 1 2 3 4 5 ์ด์ „์—๋ฐ›์€์น˜๋ฃŒ๋ฅผ๋ถ„๋ช…ํžˆ์„ ํ˜ธํ•จ ์ด์ „์—๋ฐ›์€์น˜๋ฃŒ๋ฅผ์•ฝ๊ฐ„์„ ํ˜ธํ•จ ์ด๋ฒˆ์—ฐ๊ตฌ์˜์น˜๋ฃŒ๋ฐฉ๋ฒ•์„์•ฝ๊ฐ„์„ ํ˜ธํ•จ ์ด๋ฒˆ์—ฐ๊ตฌ์˜์น˜๋ฃŒ๋ฐฉ๋ฒ•์„๋ถ„๋ช…ํžˆ์„ ํ˜ธํ•จ 0 1 2 3 4 ๋™์ผํ•œ์น˜๋ฃŒ๋ฐฉ๋ฒ•์„๋ถ„๋ช…ํžˆ๋ฐ›์ง€์•Š์„๊ฒƒ์ž„ ๋™์ผํ•œ์น˜๋ฃŒ๋ฐฉ๋ฒ•์„์•„๋งˆ๋„๋ฐ›์ง€์•Š์„๊ฒƒ์ž„ ๋™์ผํ•œ์น˜๋ฃŒ๋ฐฉ๋ฒ•์„๋ฐ›์„์ˆ˜๋„์žˆ์Œ ๋™์ผํ•œ์น˜๋ฃŒ๋ฐฉ๋ฒ•์„๋ถ„๋ช…ํžˆ๋ฐ›์„๊ฒƒ์ž„ 1 2 3 4 ์ ˆ๋Œ€๋กœ์ถ”์ฒœํ•˜์ง€์•Š์„๊ฒƒ์ž„ ์•„๋งˆ๋„์ถ”์ฒœํ•˜์ง€์•Š์„๊ฒƒ์ž„ ์ถ”์ฒœํ• ์ˆ˜๋„์žˆ์Œ ๋ถ„๋ช…ํžˆ์ถ”์ฒœํ• ๊ฒƒ์ž„ 1 2 3 4 ์ง€๊ทนํžˆ๋ถˆ๋งŒ์กฑ ๋งค์šฐ๋ถˆ๋งŒ์กฑ ๋ถˆ๋งŒ์กฑ ๋งŒ์กฑ ๋งค์šฐ๋งŒ์กฑ ์ง€๊ทนํžˆ๋งŒ์กฑ 1 2 3 4 5 6 Fig. 2. Korean Version of the Overactive Bladder Satisfaction with Treatment Questionnaire for patients with overactive bladder. www.einj.org 317

INJ Lee, et al. Linguistic Validation of TS-VAS and OAB-SAT-q DISCUSSION This study presented the first linguistic validation of the TS- VAS and OAB-SAT-q, which are used to evaluate patients satisfaction with their treatment. Linguistic validation is the process of investigating the reliability, conceptual equivalence, and content validity of translations of PRO measures. According to the universal translation methodology, the process of validation consists of permission for translation, forward translation, reconciliation, back-translation, cognitive debriefing, and proofreading [11]. Forward translations were performed simultaneously by 2 separate bilingual speakers. One was a 19-year-old Korean woman who had lived in Phuket, Thailand for 17 years. The other was a 24-yearold Korean man who had lived in the state of Maryland in the USA for 4.5 years, before becoming a university student majoring in Business Administration at Korea University. The forward translators in the present study were experienced bilingual speakers who were involved in the forward translation process for other questionnaires. Subsequently, reconciliation was performed to resolve discrepancies between the 2 forward translations. The reconciler altered the forward translations to make them suitable, or offered new forward translations, if necessary. The back-translation of the reconciled version involved another bilingual speaker who was fluent in the Korean and English languages, but was not involved in the previous steps of the forward translation process. Cognitive debriefing interviews were performed to gather data on the patients interpretation of the translation. This process ensured that the meaning intended by the developer was retained in translation and was also understood by the patients in the same way [11]. The authors performed the validation process according to this universal process of translation validation. The VAS is a valid and reliable measure for rating pain, and is widely accepted as a way to quantitatively evaluate QoL [12]. In adults, it has been observed to be a responsive and valid tool for measuring satisfaction, feelings, and emotional function [8,13-15]. VAS-based questionnaires could be a useful tool for assessing satisfaction specific to treatment with any medication [8]. The TS-VAS, which is widely used to evaluate patient satisfaction, reflects a patient s subjective perceptions or opinions regarding the treatment experience [8]. OAB is a condition that negatively effects patients well-being, and is a chronic disease that requires long-term medical therapy. Patient satisfaction is an important issue when determining whether to continue a drug for the treatment of OAB. Therefore, it is important for physicians to evaluate patient satisfaction. Previous investigators have used King s Health Questionnaire [16], the OAB questionnaire [17], the Overactive Bladder Symptoms Score [18] and Benefit, Satisfaction, and Willingness to Continue questionnaires to evaluate the severity of the symptoms of OAB, their effect on QoL, and patients satisfaction with their treatment [19]. The OAB-SAT-q is a useful assessment tool for evaluating satisfaction among patients receiving treatment for OAB [10]. The OAB-SAT-q was developed by identifying concepts that are important for treatment satisfaction among patients with OAB. The questionnaire was developed and refined based on a review of existing instruments measuring treatment satisfaction, input from physicians experienced in treating OAB, and patient feedback [10]. Therefore, the findings of the current study will be helpful to domestic investigators, who will use the Korean version of the TS-VAS and OAB-SAT-q to assess treatment satisfaction and response among patients. A limitation of this study is that it did not include a reliability analysis, which would enhance the strength of the association between the scores obtained from the English- and Koreanlanguage versions. However, the content of the original questionnaires was not modified, and a reliability test can be considered for psychometric validation in the future. In conclusion, the present study reports the successful linguistic validation of the TS-VAS and OAB-SAT-q. Our results can help provide reliable PROs to physicians in Korea. REFERENCES 1. Golin CE, DiMatteo MR, Gelberg L. The role of patient participation in the doctor visit. Implications for adherence to diabetes care. Diabetes Care 1996;19:1153-64. 2. Katz JN. Patient preferences and health disparities. JAMA 2001; 286:1506-9. 3. Owens DK. Spine update. Patient preferences and the development of practice guidelines. Spine (Phila Pa 1976) 1998;23:1073-9. 4. Stach-Lempinen B, Kujansuu E, Laippala P, Metsänoja R. Visual analogue scale, urinary incontinence severity score and 15 D--psychometric testing of three different health-related quality-of-life instruments for urinary incontinent women. Scand J Urol Nephrol 2001;35:476-83. 5. Ohnhaus EE, Adler R. Methodological problems in the measure- 318 www.einj.org

Lee, et al. Linguistic Validation of TS-VAS and OAB-SAT-q INJ ment of pain: a comparison between the verbal rating scale and the visual analogue scale. Pain 1975;1:379-84. 6. Abdel-Fattah M, Ramsay I, Barrington JW. A simple visual analogue scale to assess the quality of life in women with urinary incontinence. Eur J Obstet Gynecol Reprod Biol 2007;133:86-9. 7. Hayes MH, Patterson DG. Experimental development of the graphic rating method. Psychol Bull 1921;18:98-9. 8. Chapman CR, Casey KL, Dubner R, Foley KM, Gracely RH, Reading AE. Pain measurement: an overview. Pain 1985;22:1-31. 9. Brokelman RB, Haverkamp D, van Loon C, Hol A, van Kampen A, Veth R. The validation of the visual analogue scale for patient satisfaction after total hip arthroplasty. Eur Orthop Traumatol 2012;3: 101-5. 10. Margolis MK, Fox KM, Cerulli A, Ariely R, Kahler KH, Coyne KS. Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q). Neurourol Urodyn 2009; 28:416-22. 11. Eremenco SL, Cella D, Arnold BJ. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Eval Health Prof 2005;28:212-32. 12. Stinson JN, Kavanagh T, Yamada J, Gill N, Stevens B. Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents. Pain 2006;125:143-57. 13. Guyatt GH, Townsend M, Berman LB, Keller JL. A comparison of Likert and visual analogue scales for measuring change in function. J Chronic Dis 1987;40:1129-33. 14. Jaeschke R, Singer J, Guyatt GH. A comparison of seven-point and visual analogue scales. Data from a randomized trial. Control Clin Trials 1990;11:43-51. 15. Singer AJ, Thode HC Jr. Determination of the minimal clinically significant difference on a patient visual analog satisfaction scale. Acad Emerg Med 1998;5:1007-11. 16. Margolis MK, Vats V, Coyne KS, Kelleher C. Establishing the content validity of the King s Health Questionnaire in men and women with overactive bladder in the US. Patient 2011;4:177-87. 17. Oh SJ, Son H, Kim SW, Lee KS, Choo MS, Kim SO, et al. Psychometric properties of the Korean Version of the Overactive Bladder Questionnaire (OAB-q) in a Korean population. Int Neurourol J 2012;16:77-85. 18. Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, et al. Symptom assessment tool for overactive bladder syndrome: overactive bladder symptom score. Urology 2006;68:318-23. 19. Pleil AM, Coyne KS, Reese PR, Jumadilova Z, Rovner ES, Kelleher CJ. The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue--the BSW. Value Health 2005;8 Suppl 1:S25-34. www.einj.org 319